AV
MRNA icon

ASR Vermogensbeheer’s Moderna MRNA Stock Holding History

ASR Vermogensbeheer’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,107
Closed -$493K – 558
2025
Q3 		$493K Sell
19,107
-220
-1% -$6.14K 0.01% 485
2025
Q2 		$533K Sell
19,327
-2,320
-11% -$61.1K 0.01% 482
2025
Q1 		$614K Buy
+21,647
New +$768K 0.01% 468

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ASR Vermogensbeheer's MRNA Position: Q4 2025 in Review

ASR Vermogensbeheer sold out of Moderna (MRNA) in Q4 2025, closing a stake of 19,107 shares — an estimated $493K sold.

ASR Vermogensbeheer first reported a position in MRNA in Q1 2025 and held it in 3 quarters. The position peaked at $614K in Q1 2025. 675 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • ASR Vermogensbeheer reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • ASR Vermogensbeheer sold 19,107 Moderna shares in Q4 2025, an estimated $493K.
  • ASR Vermogensbeheer first reported a position in Moderna in Q1 2025 and held it in 3 quarters.
  • ASR Vermogensbeheer's Moderna position peaked at $614K in Q1 2025.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on ASR Vermogensbeheer's 13F filing for Q4 2025, filed 3 Feb 2026.